A new outpatient treatment for mesothelioma victims showed signs of success in a woman who was exposed to asbestos in her childhood. She was diagnosed with mesothelioma in 2008 and did not respond to the conventional chemotherapy treatment. This prompted her to visit NeoPlas Innovation in Nashville, Tennessee.
After two months of treatment under this new protocol, CT scans showed the cancer was stabilizing, larger tumors were shrinking, and her overall condition improved. While these results are early and conclusions cannot yet be drawn, they are similar to the protocol’s success against other aggressive cancers.
The protocol is offered for those patients who qualify and have colon cancer, kidney cancer, pancreatic cancer, melanoma, or certain sarcomas.
This treatment is a combination of two existing medications: lovastatin and interferon. While lovastatin is typically used to lower cholesterol, prior tests proved that it had a significant effect against mesothelioma cells in laboratory cultures.
For more information, visit the NeoPlas web site or read the press release
